An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Weave (NYSE: WEAV) will release its first quarter 2024 financial results on May 1, 2024, followed by a conference call to discuss the results and provide a business update.
Weave (NYSE: WEAV) pubblicherà i risultati finanziari del primo trimestre del 2024 il 1° maggio 2024, seguiti da una conferenza telefonica per discutere i risultati e fornire un aggiornamento aziendale.
Weave (NYSE: WEAV) publicará sus resultados financieros del primer trimestre de 2024 el 1 de mayo de 2024, seguido por una llamada de conferencia para discutir los resultados y proporcionar una actualización del negocio.
Weave (NYSE: WEAV)는 2024년 5월 1일에 2024년 1분기 재무 결과를 발표할 예정이며, 결과를 논의하고 사업 업데이트를 제공하기 위한 컨퍼런스 콜을 진행할 예정입니다.
Weave (NYSE: WEAV) publiera ses résultats financiers pour le premier trimestre 2024 le 1er mai 2024, suivis d'une conférence téléphonique pour discuter des résultats et fournir une mise à jour sur l'entreprise.
Weave (NYSE: WEAV) wird am 1. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 veröffentlichen, gefolgt von einer Telefonkonferenz zur Diskussion der Ergebnisse und einem Geschäftsupdate.
Positive
None.
Negative
None.
LEHI, Utah--(BUSINESS WIRE)--
Weave (NYSE: WEAV), a leading all-in-one experience software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the first quarter 2024 after U.S. markets close on Wednesday, May 1, 2024. Company management will host a conference call and webcast at 4:30 p.m. ET to discuss Weave’s financial results and provide a business update.
Individuals interested in listening to the conference call may do so by dialing (412) 902-1020 or toll-free at (877) 502-7186. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Weave’s website at investors.getweave.com.
About Weave
Weave is the all-in-one experience platform for small- and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire customer journey. Weave’s software solutions transform how local healthcare providers attract, communicate with and engage patients to grow their practice. In the past year, Weave has been named a G2 leader in Patient Relationship Management, Patient Engagement, Optometry, and Dental Practice Management software. To learn more, visit getweave.com/newsroom/.
Investor Contact:
Mark McReynolds
Head of Investor Relations
ir@getweave.com
Media Contact:
Natalie House
Senior Director of Content & Communications
pr@getweave.com
Source: Weave
Weave will release its first quarter 2024 financial results after U.S. markets close on Wednesday, May 1, 2024.
The ticker symbol for Weave is WEAV.
Individuals can listen to the conference call by dialing (412) 902-1020 or toll-free at (877) 502-7186. The webcast can be accessed on Weave's investor relations page at investors.getweave.com.
as the pace of innovation continues, it is growing more difficult to see the value of technology. often meaningful information is inaccessible at the time it would be most beneficial. weave threads together data, software and communication platforms to build stronger relationships at the point of contact by making valuable information instantly available in simple and intuitive formats. this delivers improved productivity, better collaboration and greater insights making it easier to meet the needs of patients and to build better business and clinical outcomes.
